LLY

Amgen Rides Renewed GLP-1 Obesity Momentum
Amgen (AMGN) is now being treated in positioning as an emerging GLP-1 obesity and diabetes play, with investors increasingly framing the stock around its obesity pipeline rather than only its legacy...
Apr 9, 2026
1 min read
Vanguard ETFs Face Rotation and Strategy Shifts
Vanguard updates prompt investors to rethink growth vs. income and index breadth as market leadership shifts.
Apr 4, 2026
4 min read
US Stocks Rise as Growth Sectors Lead
Markets advance as growth sectors push higher; crude's slide dents energy, consumer stocks diverge.
Mar 31, 2026
3 min read
Vanguard shifts to disaggregated SEC reporting
Vanguard restructures reporting: subsidiaries will report holdings separately; amendments say no shares were sold.
Mar 26, 2026
4 min read
Mixed Global Markets and Key Corporate Moves
Asian stocks rise on Fed rate-cut hopes; energy, tech sectors see major funding and strategic moves.
Feb 11, 2026
6 min read
Analysts Shift on Key Blue-Chip and Growth Names
Analysts reevaluate top sectors as tech pivots on AI and energy, finance, and healthcare face shifting growth dynamics.
Feb 8, 2026
7 min read
Maersk Cuts Jobs as Freight Rates Slide Further
Maersk trims 1,000 jobs as freight rates drop 23%, pressuring profits amid weak demand.
Feb 5, 2026
5 min read
Hims jolts weight‑loss drug market with $49 Wegovy pill
Hims disrupts weight-loss market with $49 Wegovy pill, pressuring Novo Nordisk and Eli Lilly shares.
Feb 5, 2026
4 min read
AI Jitters Hit Software, While Uber, Eli Lilly Outline Growth Plans
Software stocks fall on AI concerns; Uber and Eli Lilly reveal ambitious growth and innovation strategies.
Feb 4, 2026
5 min read
Big Tech, AI and Tariffs Shake Up Market Leaders
Tech giants navigate AI growth, tariffs, and shifting demand amid strategic pivots and market uncertainties.
Jan 24, 2026
9 min read
Novo’s Wegovy pill posts strong US launch data
Novo’s Wegovy pill outpaces rivals with strong US launch, boosting market optimism and shares.
Jan 23, 2026
3 min read